（文章来源：每日经济新闻） 每经AI快讯，1月27日，*ST四环(000518.SZ)公告称，公司2024年度经审计的净利润为负值且营业收入 低于3亿元，股票自2025年4月30日开市起被实施退市风险警示。若公司2025年度报告披露后出现经审计 的利润总额、净利润、扣除非经常性损益后的净利润三者孰低为负值，且扣除后的营业收入低于3亿元 等情形之一的，公司股票将面临被终止上市的风险。公司预计2025年净利润亏损3000万元至4000万元， 预计2025年度扣除非经常性损益后的净利润为-4,600万元至-3,300万元，扣除后营业收入为33,000万元至 35,000万元，该财务数据未经会计师事务所审计，最终财务数据以公司正式披露的经审计后的2025年年 度报告为准。在年度报告披露前，公司将每十个交易日披露一次风险提示公告。 ...

Core Viewpoint - The company expects revenue for 2025 to be between 340 million to 360 million yuan, an increase from 204 million yuan in the same period last year, while net profit attributable to shareholders is projected to be a loss of 30 million to 40 million yuan, improving from a loss of 110 million yuan in the previous year, indicating a year-on-year growth of 63.63% to 72.73% in net profit [1] Revenue Summary - The revenue growth is primarily driven by a significant increase in sales from the wholly-owned subsidiary, Chenwei Ecological Park [1] - The expected revenue for 2025 is projected to be between 340 million to 360 million yuan, compared to 204 million yuan in the previous year [1] Profit Summary - The improvement in net profit is attributed to a reduction in asset impairment losses and operating expenses, as well as effective cost control measures at the controlling subsidiary, Beijing Sihuan Biological Pharmaceutical [1] - The projected net loss for 2025 is between 30 million to 40 million yuan, a notable improvement from the previous year's loss of 110 million yuan [1] Risk Warning - Due to the negative net profit in 2024 and revenue below 300 million yuan, the company's stock will be subject to delisting risk warning starting April 30, 2025, and may face termination of listing if financial indicators meet specified conditions [1]

Core Viewpoint - The company is facing a delisting risk warning starting from April 30, 2025, due to potential conditions outlined in the stock listing rules, which could lead to termination of its stock listing after the 2025 annual report is disclosed [1] Financial Performance - The company has announced an earnings forecast for 2025, expecting a non-recurring net profit of between -46 million yuan and -33 million yuan, with operating revenue projected to be between 330 million yuan and 350 million yuan, which is unaudited [1] - The company will provide risk warnings every ten trading days until the annual report is disclosed [1]

股 票 代 码 ： 0 0 0 5 1 8 股 票 简 称 ： * ST 四 环 公 告 编 号 ： 临 - 2 0 2 6 - 0 1 号 江苏四环生物股份有限公司 2025 年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间：2025 年 1 月 1 日至 2025 年 12 月 31 日。 2、业绩预告情况：股票交易已被实施财务类退市风险警示后的首个会计年 度、预计净利润为负值 | | | | | | 单位：万元 | | --- | --- | --- | --- | --- | --- | | 项 目 | 本报告期 | | | | 上年同期 | | 利润总额 | -4,200 | | ～ | -3,200 | -11,373.31 | | | 比上年同期增长 | 63.07% | ～ | 71.86% | | | 归属于上市公司股 | -4,000 | | ～ | -3,000 | -10,999.37 | | 东的净利润 | 比上年同期增长 | 63.63% | ～ | 72.73% | | | 扣除 ...

Group 1 - The biopharmaceutical sector increased by 0.19% on January 21, with Nearshore Protein leading the gains [1] - The Shanghai Composite Index closed at 4116.94, up 0.08%, while the Shenzhen Component Index closed at 14255.12, up 0.7% [1] - Key stocks in the biopharmaceutical sector showed significant price increases, with Nearshore Protein rising by 6.37% to a closing price of 48.76 [1] Group 2 - The biopharmaceutical sector experienced a net inflow of 77.04 million yuan from institutional investors, while retail investors saw a net outflow of 284 million yuan [2] - Major stocks like Watson Bio and Ganli Pharmaceutical attracted significant institutional investment, with net inflows of 64.45 million yuan and 55.25 million yuan, respectively [3] - Retail investors showed a negative trend in several stocks, with Watson Bio and Ganli Pharmaceutical experiencing net outflows of 33.30 million yuan and 39.14 million yuan, respectively [3]

Market Overview - As of January 19, the Shanghai Composite Index rose by 0.29% to close at 4114.0001 points, while the Shenzhen Component Index increased by 0.09% to close at 14294.053 points [1] Top Gainers in Hunan Stocks - Changlan Technology opened at 20.800 and closed at 22.990, achieving a daily increase of 7.83%, with a highest price of 23.350 and a lowest price of 20.580, trading volume reached 310,056 lots [2] - Changgao Electric New opened at 9.630 and closed at 10.220, marking a daily rise of 7.58%, with a highest price of 10.300 and a lowest price of 9.590, trading volume was 907,740 lots [2] - Jinbei Electric opened at 13.550 and closed at 14.340, reflecting a daily increase of 5.75%, with a highest price of 14.340 and a lowest price of 13.550, trading volume was 530,320 lots [2] - Boyun New Materials opened at 11.580 and closed at 12.380, showing a daily rise of 5.72%, with a highest price of 12.640 and a lowest price of 11.510, trading volume reached 683,175 lots [2] - *ST Biological opened at 8.360 and closed at 8.930, achieving a daily increase of 5.06%, with a highest price of 8.930 and a lowest price of 8.360, trading volume was 39,799 lots [2] Top Losers in Hunan Stocks - Hengli Retreat opened at 0.160 and closed at 0.150, experiencing a daily drop of 11.76%, with a highest price of 0.170 and a lowest price of 0.150, trading volume was 611,606 lots [3] - Kaimete Gas opened at 23.120 and closed at 22.590, reflecting a daily decline of 2.67%, with a highest price of 23.290 and a lowest price of 22.500, trading volume reached 566,571 lots [3] - ST Jiajia opened at 6.700 and closed at 6.540, marking a daily decrease of 2.39%, with a highest price of 6.760 and a lowest price of 6.540, trading volume was 52,505 lots [3] - Tuowei Information opened at 33.940 and closed at 33.770, showing a daily drop of 1.29%, with a highest price of 34.400 and a lowest price of 33.630, trading volume reached 53,496 lots [3] - Aoshikang opened at 41.650 and closed at 41.130, experiencing a daily decline of 1.25%, with a highest price of 41.650 and a lowest price of 40.850, trading volume was 32,232 lots [3]

Market Overview - As of December 30, the Shanghai Composite Index closed at 3965.1159 points, unchanged at 0% [1] - The Shenzhen Component Index rose by 0.49%, closing at 13604.067 points [1] Top Gainers in Hunan Stocks - *ST Zhanggu opened at 7.570 and closed at 7.570, with a gain of 4.99% [2] - *ST Gaosi opened at 8.230 and closed at 8.550, with a gain of 4.14% [2] - Mengjie Co., Ltd. opened at 3.910 and closed at 4.030, with a gain of 2.81% [2] - Keli'er opened at 13.390 and closed at 13.610, with a gain of 2.48% [2] - Changlan Technology opened at 18.310 and closed at 18.890, with a gain of 1.94% [2] Top Losers in Hunan Stocks - Hengli Tui opened at 0.160 and closed at 0.150, with a loss of 11.76% [3] - Dianguang Media opened at 11.580 and closed at 10.350, with a loss of 10.00% [3] - Boyun New Materials opened at 12.050 and closed at 11.720, with a loss of 4.95% [3] - Hunan Silver opened at 6.960 and closed at 6.990, with a loss of 3.98% [3] - *ST Biology opened at 9.190 and closed at 8.830, with a loss of 3.29% [3]

Group 1 - The core viewpoint of the article is that *ST SiHuan (000518.SZ) has a year-round seedling sales business, with spring and autumn being peak sales seasons [1] Group 2 - The company engages in seedling sales throughout the year, indicating a stable business model [1] - Spring and autumn are identified as the peak seasons for sales, suggesting potential for increased revenue during these periods [1]

Group 1 - The biopharmaceutical sector increased by 0.18% on December 25, with Jindike leading the gains [1] - The Shanghai Composite Index closed at 3959.62, up 0.47%, while the Shenzhen Component Index closed at 13531.41, up 0.33% [1] - Key stocks in the biopharmaceutical sector showed various performance, with Jindike (688670) rising by 4.66% to a closing price of 22.45 [1] Group 2 - The biopharmaceutical sector experienced a net outflow of 307 million yuan from institutional investors, while retail investors saw a net inflow of 359 million yuan [2] - Notable declines included Te Bao Biological (688278), which fell by 3.14% to a closing price of 80.90 [2] - The trading volume and turnover for various stocks in the sector varied significantly, with Wan Ze Co. (000534) achieving a turnover of 488 million yuan [1][2] Group 3 - Jindike (688670) had a net inflow of 25.23 million yuan from institutional investors, while retail investors had a net outflow of 23.95 million yuan [3] - Other stocks like Zhi Xiang Jin Tai (688443) and Shen Zhou Cell (688520) also showed mixed net inflows and outflows from different investor categories [3] - The overall trend indicates a divergence in investor sentiment, with institutional investors pulling back while retail investors increased their positions [2][3]

Group 1 - The Shanghai Composite Index closed at 3958.00 points, above the annual line, with a change of 0.43% [1] - The total trading volume of A-shares reached 1552.045 billion yuan [1] - A total of 131 A-shares have surpassed the annual line, with notable stocks including Xusheng Group, Chongqing Port, and *ST Zhisheng showing significant deviation rates of 8.27%, 8.15%, and 4.95% respectively [1] Group 2 - Stocks with the highest deviation rates from the annual line include: - Xusheng Group (10.01% increase, 8.74% turnover rate, latest price 15.38 yuan, deviation rate 8.27%) - Chongqing Port (10.02% increase, 2.26% turnover rate, latest price 5.82 yuan, deviation rate 8.15%) - *ST Zhisheng (4.98% increase, 3.86% turnover rate, latest price 11.60 yuan, deviation rate 4.95%) [1] - Other stocks with smaller deviation rates that have just crossed the annual line include Hu塑股份, Hu鑫股份, and Heng申新材 [1]